Triglyceride vs Ethyl Ester Fish Oil: Why Form Determines Absorption
Most fish oil sold in supplement aisles is ethyl ester (EE) — a concentrated form created by chemically processing natural fish oil to increase EPA and DHA content. Ethyl ester production is less expensive and allows higher percentages of EPA and DHA per capsule, which is why it dominates the market. But this chemical modification comes at a measurable cost to bioavailability.
Natural fish oils carry EPA and DHA bound to a triglyceride backbone — the same structure found in food sources like salmon and sardines. Re-esterified triglyceride (rTG) form preserves or restores this natural structure in concentrated supplements. Research published in Prostaglandins, Leukotrienes and Essential Fatty Acids examined 72 volunteers taking approximately 3.3g of EPA plus DHA daily from different formulations for two weeks. Re-esterified triglycerides demonstrated superior bioavailability (124% relative to natural fish oil) compared with ethyl esters, which showed inferior bioavailability (73% relative to natural fish oil).
The mechanism explains why: both forms require pancreatic lipase to release EPA and DHA from their chemical backbone, but lipase works less efficiently on ethyl esters than on triglycerides. Ethyl esters also require a fatty meal for adequate absorption, while triglyceride forms show more consistent uptake across fasting and fed states.
Krill oil offers omega-3 fatty acids bound to phospholipids — a third structural form that many researchers consider the most bioavailable of all. Phospholipids carry EPA and DHA directly across intestinal membranes without requiring the same enzymatic processing. The tradeoff: krill oil contains significantly less EPA and DHA per gram than concentrated fish oil products, and costs substantially more per dose of EPA and DHA.
FormulaForge offers omega-3 fatty acids in re-esterified triglyceride form — the concentrated fish oil structure with the strongest combination of high EPA/DHA content and documented absorption advantage over ethyl esters.
PMID: 20638827
How to Tell If Your Fish Oil Is Rancid (And Why It Matters)
Omega-3 fatty acids are among the most chemically unstable nutrients in supplement form. EPA and DHA contain multiple double bonds that are highly susceptible to oxidation — a process that begins the moment the oil is processed and accelerates with light, heat, and air exposure. Oxidized fish oil forms lipid peroxides, aldehydes, and other secondary oxidation products that may not only reduce the oil's beneficial activity but may actively promote inflammation.
Published research on the oxidative quality of commercial fish oil supplements paints a sobering picture. A review on oxidation of marine omega-3 supplements found that many commercially available products significantly exceed the voluntary oxidation safety standards set by industry bodies — with peroxide values (measuring primary oxidation) and anisidine values (measuring aldehydic secondary products) above recommended thresholds in a substantial proportion of products tested. More recent analyses have confirmed that high rates of commercial products continue to exceed GOED (Global Organization for EPA and DHA) voluntary monograph TOTOX limits at point of purchase.
There are two practical ways to assess whether your fish oil has gone rancid. The first is sensory: rancid fish oil has a notably sharp, "fishy," or painty odor that goes beyond normal fish smell. A fresh, high-quality triglyceride oil should smell faintly of the sea — not like a garbage can near a dock. Cutting open a capsule and smelling the oil directly is a meaningful test. The second method is to check the manufacturer's third-party certificate of analysis (CoA) for peroxide value (PV), anisidine value (AV), and TOTOX value. PV should be under 5 mEq/kg; TOTOX should be under 26 per GOED standards.
What to look for in storage: fish oil oxidizes faster when exposed to heat, light, and oxygen. Keep capsules in a cool, dark location and refrigerate liquid oils after opening. Opaque packaging, nitrogen flushing at fill, and enteric coating all slow oxidative degradation.
FormulaForge sources omega-3 from manufacturers with current third-party oxidative testing documentation. We do not use ethyl ester oils, which have higher surface area exposure and greater oxidation susceptibility than triglyceride forms.
PMID: 23738326
EPA vs DHA: Which Omega-3 Does What — and How to Choose by Goal
EPA (eicosapentaenoic acid) and DHA (docosahexaenoic acid) are the two long-chain omega-3 fatty acids that drive the health research on fish consumption. While both are essential and work synergistically, they have distinct primary roles in human physiology — a distinction that matters when selecting a supplement formulation.
EPA is primarily an anti-inflammatory mediator. It competes with arachidonic acid (an omega-6 fatty acid) for the same enzymatic pathways, reducing the production of pro-inflammatory eicosanoids. EPA is also a precursor to specialized pro-resolving mediators (SPMs) — compounds that actively facilitate the resolution of inflammatory processes rather than merely suppressing them. Research on omega-3 and mood specifically identifies EPA as the dominant active component: meta-analyses of omega-3 supplementation for mood support consistently find that formulas providing more than 60% EPA relative to total EPA+DHA content show the most robust effects, while pure DHA formulas typically show no measurable benefit. The 2017 meta-analysis examining omega-3 PUFAs and mood support (PMID 28466678) identified this EPA-dominant pattern across multiple trials.
DHA is a structural fatty acid. It is a primary component of neuronal membranes in the brain, comprising approximately 97% of the omega-3 in the brain and 93% of the omega-3 in the retina. DHA is critically important during neurodevelopment — prenatal and early postnatal DHA intake is consistently associated with visual development and brain structure outcomes. In adults, DHA maintains membrane fluidity in neurons, affects synaptic transmission, and is associated with cognitive health. While DHA plays a role in the omega-6 to omega-3 ratio, its mechanism is more structural than EPA's acute inflammatory signaling.
Practical guidance for goal selection: for general inflammatory support and cardiovascular health, a high-EPA formula (EPA > DHA) is typically preferred by practitioners. For brain and retinal structural support, especially during pregnancy or in populations with low DHA status, a balanced or DHA-forward formula may be more appropriate. For most adults pursuing general wellness, a standard 2:1 or 3:2 EPA:DHA ratio (as found in natural fish oil) covers both functions adequately.
PMID: 28466678 · PMID: 25149823
Omega-3 and Heart Health: What the REDUCE-IT Trial Actually Found
The cardiovascular research on omega-3 fatty acids is one of the most extensively studied and simultaneously most debated areas in clinical nutrition. Several large trials examining standard-dose fish oil (1g/day) found no significant reduction in major cardiovascular events, contributing to a perception that omega-3 supplementation was ineffective for heart health. The REDUCE-IT trial (2018, published in the New England Journal of Medicine, PMID 30018259) changed that narrative — but with an important caveat about form and dose.
REDUCE-IT tested icosapent ethyl (a prescription-grade highly purified EPA ethyl ester) at 4 grams per day in 8,179 adults with elevated triglycerides on statin therapy. After a median follow-up of 4.9 years, the trial found a 25% relative risk reduction in major adverse cardiovascular events (MACE) — including cardiovascular death, nonfatal myocardial infarction, and stroke — compared with the mineral oil placebo. This was a statistically significant result that prompted FDA approval of icosapent ethyl for cardiovascular risk reduction in high-risk adults.
The contrast with the STRENGTH trial is instructive. STRENGTH tested a different compound — an EPA+DHA ethyl ester combination — at the same 4g/day dose in a similar high-risk population. STRENGTH was terminated early due to futility: the EPA+DHA ethyl ester formula showed no cardiovascular benefit. Researchers have proposed several explanations, including possible differences between pure EPA vs combined EPA+DHA, the higher dose achievable with a concentrated EE formula, and questions about whether the mineral oil control in REDUCE-IT may have inflated the apparent benefit.
The clinical takeaway from this literature is nuanced: omega-3 fatty acids at standard over-the-counter doses have modest to no demonstrated cardiovascular effect in primary prevention populations. High-dose EPA (4g/day of prescription-grade icosapent ethyl) has demonstrated benefit in high-risk adults on statins. Whether high-dose triglyceride-form fish oil at equivalent EPA doses would show comparable effects is an open research question.
FormulaForge makes no claim that any omega-3 supplement prevents heart attacks, treats cardiovascular disease, or is equivalent to prescription icosapent ethyl. The information above reflects published structure/function research. Consult your healthcare provider before starting any supplement regimen, especially if you have cardiovascular disease or take medications.
PMID: 30018259
How to Get Enough Omega-3 From Food and Supplements — and Why Most People Fall Short
The omega-3 to omega-6 ratio in the modern Western diet has shifted dramatically from the evolutionary baseline. Estimates of ancestral omega-6 to omega-3 ratios range from approximately 4:1 to 1:1. Modern Western diets, heavily reliant on seed oils (soybean, corn, sunflower) and processed foods, typically produce ratios of 15:1 to 17:1. This imbalance is relevant because omega-6 arachidonic acid competes directly with EPA for the same inflammatory enzymes — meaning high omega-6 intake blunts the effect of omega-3 supplementation.
The most EPA and DHA-dense food sources are fatty cold-water fish: wild-caught salmon provides approximately 1,500–2,000mg EPA+DHA per 100g serving; mackerel approximately 2,500mg; sardines approximately 1,400mg; herring approximately 1,700mg. The American Heart Association recommends two servings of fatty fish per week — approximately 500mg EPA+DHA per day from dietary sources. Research consistently shows that most adults in the United States, Canada, and Europe consume substantially less than this through diet alone.
Plant-based omega-3 sources (flaxseed, chia, walnuts) contain ALA (alpha-linolenic acid), a short-chain omega-3 that the body must convert to EPA and DHA. Conversion efficiency is poor: studies estimate that humans convert approximately 5–10% of ALA to EPA and less than 1% to DHA. For individuals who do not consume fish, supplementation with algal oil (which provides DHA and some EPA directly, without the fish oil chain) is the most direct plant-derived route to long-chain omega-3 status.
Dosing guidance varies by goal. For general wellness in adults, 1–2 grams of combined EPA+DHA daily is a commonly used range. For active inflammatory support, practitioners often use 2–4 grams EPA+DHA daily. Pregnant and nursing women may benefit from focused DHA supplementation (200–300mg DHA/day minimum is widely recommended by obstetric guidelines). All dosing should be discussed with a healthcare provider, particularly at higher doses where blood-thinning effects may become relevant.
Important: FormulaForge supplements are not intended to diagnose, treat, cure, or prevent any disease. Always consult your healthcare provider before starting any new supplement regimen, especially if you take anticoagulant medications, have a bleeding disorder, or are pregnant.
PMID: 25149823